Development of Atılım Kinesiophobia Scale
Development, Validity and Reliability of Atılım Kinesiophobia Scale
1 other identifier
observational
150
1 country
1
Brief Summary
Background: Kinesiophobia or fear of movement, is defined as an excessive and irrational fear of physical movement to avoid painful injury, harm or re-injury. The existing scales measuring kinesiophobia are thought to have some limitations (the difficulty of patients to understand and answer the questions, the presence of questions that are not suitable for the patient's condition). These questionnaires may not have specific questions enough to assess fear of movement in different patient populations. Aim: The aim of this study is to develop and validate the Turkish Atılım Kinesiophobia Scale. Material/method: In the first stage of the study, research on kinesiophobia was reviewed and a total of 38 questions were created for the scale. The questions were submitted to the opinion of 11 experts working in the physiotherapy and rehabilitation field. Then A total of 100 patients with acute and chronic musculoskeletal pain completed the Turkish Atılım Kinesiophobia Scale and Tampa Scale of Kinesiophobia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 19, 2024
CompletedFirst Posted
Study publicly available on registry
February 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2024
CompletedApril 1, 2024
February 1, 2024
3 months
February 19, 2024
March 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The pilot study of the scale will be conducted with a total of 40 patients, 10 participants for each patient group.
Up to one month
item analyses and exploratory factor analysis (EFA) analysis will be performed with a sample size of 5 times the number of questions in the item pool with acute and chronic pain patients.
Up to one month
Eligibility Criteria
The study population consisted of male and female patients aged 18-70 years with complaints of acute and chronic pain due to musculoskeletal problems.
You may qualify if:
- Young, middle-aged, neurologic, geriatric patients
- aged 18-70 years with chronic musculoskeletal pain problems after acute injury or surgery will be included.
You may not qualify if:
- patients with cognitive and cooperation problems will not be included in the study.
- illiterate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atılım University
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayhan Parmaksız, PhD
İstanbul Sağlık ve Teknoloji Üniversitesi
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 19, 2024
First Posted
February 26, 2024
Study Start
January 1, 2024
Primary Completion
March 30, 2024
Study Completion
March 30, 2024
Last Updated
April 1, 2024
Record last verified: 2024-02